(Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Total investments | 35.42%43.93B | 23.55%38.34B | 22.37%36.56B | 23.94%35.04B | 23.94%35.04B | 20.44%32.44B | 15.63%31.04B | 9.60%29.88B | 1.75%28.27B | 1.75%28.27B |
-Equity investments | 2,604.59%24.18B | --20.85B | --19.67B | 21.09%19.69B | 21.09%19.69B | --894M | ---- | ---- | --16.26B | --16.26B |
-Security agree to be resell | 1,238.98%790M | 19.59%116M | 97.62%166M | 425.00%63M | 425.00%63M | 118.18%59M | -38.35%97M | -27.98%84M | -80.06%12M | -80.06%12M |
-Investments in other ventures under equity method | 23.41%6.48B | 21.40%6.13B | 22.50%6.02B | 19.96%5.69B | 19.96%5.69B | 17.81%5.25B | 13.04%5.05B | 9.87%4.91B | 12.48%4.74B | 12.48%4.74B |
-Short term investments | -61.85%9.22B | -66.55%8.04B | -66.17%7.82B | 26.67%7.11B | 26.67%7.11B | 15.79%24.17B | 16.81%24.05B | 10.10%23.1B | -73.94%5.61B | -73.94%5.61B |
-Other invested assets | 57.69%3.26B | 73.67%3.21B | 62.50%2.89B | 51.34%2.49B | 51.34%2.49B | 30.99%2.07B | 12.95%1.85B | 5.30%1.78B | -16.70%1.64B | -16.70%1.64B |
Cash and cash equivalents | 19.32%1.03B | 12.83%1.02B | 23.66%993M | 7.25%917M | 7.25%917M | 5.58%859M | 11.12%904M | -1.22%803M | -0.43%855M | -0.43%855M |
Receivables | 20.84%16.39B | 14.40%15.76B | 17.91%15.18B | 13.44%13.52B | 13.44%13.52B | 16.21%13.56B | 21.56%13.77B | 17.32%12.88B | 15.25%11.92B | 15.25%11.92B |
-Accounts receivable | 20.84%16.39B | 14.40%15.76B | 17.91%15.18B | 13.44%13.52B | 13.44%13.52B | 16.21%13.56B | 21.56%13.77B | 17.32%12.88B | 15.25%11.92B | 15.25%11.92B |
Accrued investment income | 34.56%292M | 23.18%287M | 44.79%236M | 48.43%236M | 48.43%236M | 86.65%217M | 100.69%233M | 97.32%163M | 86.07%159M | 86.07%159M |
Prepaid assets | 20.09%2.94B | 21.23%2.98B | 28.40%2.72B | 20.62%2.17B | 20.62%2.17B | 15.53%2.44B | 15.78%2.46B | 8.40%2.12B | 4.02%1.8B | 4.02%1.8B |
Deferred policy acquisition costs | 17.60%1.74B | 12.60%1.64B | 19.93%1.63B | 21.12%1.53B | 21.12%1.53B | 32.09%1.48B | 35.72%1.45B | 35.25%1.36B | 40.16%1.26B | 40.16%1.26B |
Goodwill and other intangible assets | 101.08%1.49B | -6.45%725M | -0.89%778M | -9.08%731M | -9.08%731M | -8.39%739M | -10.72%775M | -15.27%785M | -14.92%804M | -14.92%804M |
-Goodwill | ---- | ---- | ---- | 0.88%345M | 0.88%345M | ---- | ---- | ---- | -0.83%342M | -0.83%342M |
-Other intangible assets | ---- | ---- | ---- | -16.45%386M | -16.45%386M | ---- | ---- | ---- | -23.02%462M | -23.02%462M |
Other assets | 68.10%5.86B | 46.32%4.72B | 49.47%4.68B | 63.10%4.76B | 63.10%4.76B | 26.36%3.48B | 26.10%3.22B | 17.25%3.13B | 18.96%2.92B | 18.96%2.92B |
Total assets | 33.37%73.66B | 21.56%65.47B | 22.83%62.77B | 22.75%58.91B | 22.75%58.91B | 19.19%55.23B | 17.80%53.86B | 11.88%51.1B | 6.41%47.99B | 6.41%47.99B |
Liabilities | ||||||||||
Policy holders liabilities reserve | 28.86%40.19B | 14.99%35.18B | 16.12%33.94B | 15.21%31.82B | 15.21%31.82B | 16.30%31.18B | 19.56%30.6B | 16.49%29.23B | 15.02%27.62B | 15.02%27.62B |
Payables | 16.06%4.67B | 16.59%4.61B | 23.41%4.41B | 16.94%3.82B | 16.94%3.82B | 18.03%4.02B | 16.47%3.96B | 7.40%3.57B | -4.43%3.26B | -4.43%3.26B |
-Accounts payable | 16.06%4.67B | 16.59%4.61B | 23.41%4.41B | 16.94%3.82B | 16.94%3.82B | 18.03%4.02B | 16.47%3.96B | 7.40%3.57B | -4.43%3.26B | -4.43%3.26B |
Long term debt and capital lease obligation | 0.04%2.73B | 0.04%2.73B | 0.04%2.73B | 0.04%2.73B | 0.04%2.73B | 0.03%2.73B | 0.04%2.73B | 0.05%2.73B | 0.02%2.73B | 0.02%2.73B |
-Long term debt | 0.04%2.73B | 0.04%2.73B | 0.04%2.73B | 0.04%2.73B | 0.04%2.73B | 0.03%2.73B | 0.04%2.73B | 0.05%2.73B | 0.02%2.73B | 0.02%2.73B |
Unrepurchased pre-sale securities | 131.89%967M | -22.05%410M | 65.27%433M | 160.00%247M | 160.00%247M | 138.60%417M | 80.07%526M | 48.48%262M | 46.49%95M | 46.49%95M |
Other liabilities | 73.18%2.84B | 32.60%1.87B | 44.65%1.91B | 42.06%1.94B | 42.06%1.94B | 16.00%1.64B | 9.40%1.41B | -7.98%1.32B | 2.80%1.37B | 2.80%1.37B |
Total liabilities | 28.50%51.38B | 14.25%44.8B | 17.00%43.41B | 15.63%40.55B | 15.63%40.55B | 15.79%39.99B | 17.78%39.21B | 13.30%37.1B | 11.17%35.07B | 11.17%35.07B |
Shareholders'equity | ||||||||||
Share capital | 0.00%831M | 0.00%831M | 0.00%831M | 0.00%831M | 0.00%831M | 0.04%831M | 0.04%831M | 0.04%831M | 0.04%831M | 0.04%831M |
-common stock | 0.00%1M | 0.00%1M | 0.00%1M | 0.00%1M | 0.00%1M | 53.37%1M | 53.37%1M | 53.61%1M | 54.32%1M | 54.32%1M |
-Preferred stock | 0.00%830M | 0.00%830M | 0.00%830M | 0.00%830M | 0.00%830M | 0.00%830M | 0.00%830M | 0.00%830M | 0.00%830M | 0.00%830M |
Paid-in capital | 7.31%2.47B | 7.24%2.44B | 6.24%2.4B | 5.25%2.33B | 5.25%2.33B | 5.05%2.3B | 4.94%2.28B | 5.89%2.26B | 6.04%2.21B | 6.04%2.21B |
Retained earnings | 31.56%23.64B | 31.32%22.66B | 28.97%21.41B | 27.71%20.3B | 27.71%20.3B | 19.47%17.97B | 14.78%17.26B | 13.36%16.6B | 9.93%15.89B | 9.93%15.89B |
Gains losses not affecting retained earnings | 86.24%-200M | 38.59%-810M | 36.70%-821M | 58.93%-676M | 58.93%-676M | 23.20%-1.45B | -4.83%-1.32B | -99.71%-1.3B | -2,447.99%-1.65B | -2,447.99%-1.65B |
Less: Treasury stock | 1.29%4.46B | 1.27%4.46B | 1.32%4.46B | 1.05%4.42B | 1.05%4.42B | 0.78%4.41B | 1.05%4.41B | 9.06%4.4B | 16.40%4.38B | 16.40%4.38B |
Total stockholders'equity | 46.16%22.27B | 41.14%20.67B | 38.37%19.36B | 42.16%18.35B | 42.16%18.35B | 29.20%15.24B | 17.91%14.64B | 8.27%13.99B | -4.69%12.91B | -4.69%12.91B |
Noncontrolling interests | --0 | --0 | -81.82%2M | -81.82%2M | -81.82%2M | -77.55%2M | -76.36%2M | 12.67%11M | 19.14%11M | 19.14%11M |
Total equity | 46.15%22.27B | 41.13%20.67B | 38.27%19.36B | 42.06%18.36B | 42.06%18.36B | 29.12%15.24B | 17.84%14.64B | 8.27%14B | -4.68%12.92B | -4.68%12.92B |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
No Data
No Data